Literature DB >> 1586109

Increased prevalence of migraine and chest pain in patients with primary Raynaud disease.

S T O'Keeffe1, N P Tsapatsaris, W P Beetham.   

Abstract

OBJECTIVE: To investigate the prevalence of headaches and recurrent chest pain in patients with primary Raynaud disease.
DESIGN: Postal survey.
SETTING: Raynaud disease clinic at the Lahey Clinic Medical Center, a tertiary care hospital. PARTICIPANTS: A consecutive series of 120 patients with primary Raynaud disease who had been observed for at least 2 years, 97 of whom received and 93 of whom completed the questionnaire, and a control group of 93 age- and sex-matched hospital employees without Raynaud phenomenon.
RESULTS: Migraine was diagnosed in 57 (61%) patients with primary Raynaud disease and in 21 (23%) of the control group (odds ratio, 5.4; 95% CI, 2.8 to 10.3). Migraine with aura and migraine without aura were more common in patients with Raynaud disease than in the control subjects (27% compared with 5%; P less than 0.001 and 34% compared with 17%; P = 0.008, respectively). Nonmigrainous headaches were more common in the control group (51% compared with 25%; P = 0.003). Chest pains were reported by 44 (47%) of the patients with Raynaud disease and by 15 (16%) of the control group (odds ratio, 4.4; CI, 2.4 to 9.3). Chest pains were more frequently reported by patients with Raynaud disease who had migraine (34 of 57, 60%) than by patients without migraine (10 of 36, 28%; P = 0.003).
CONCLUSIONS: An increased prevalence of migraine was found in patients with primary Raynaud disease. Chest pain, often diagnosed as musculoskeletal or nonspecific, was common in patients with primary Raynaud phenomenon, especially in patients who had coexisting migraine.

Entities:  

Mesh:

Year:  1992        PMID: 1586109     DOI: 10.7326/0003-4819-116-12-985

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  12 in total

Review 1.  Migraine aura pathophysiology: the role of blood vessels and microembolisation.

Authors:  Turgay Dalkara; Ala Nozari; Michael A Moskowitz
Journal:  Lancet Neurol       Date:  2010-03       Impact factor: 44.182

Review 2.  The clinical potential of endothelin receptor antagonists in cardiovascular medicine.

Authors:  C J Ferro; D J Webb
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

3.  Raynaud's phenomenon in Northern Sweden: a population-based nested case-control study.

Authors:  Albin Stjernbrandt; Hans Pettersson; Ingrid Liljelind; Tohr Nilsson; Jens Wahlström
Journal:  Rheumatol Int       Date:  2018-08-20       Impact factor: 2.631

4.  Impaired cholinergic dilator response of resistance arteries isolated from patients with Raynaud's disease.

Authors:  P J Smith; C J Ferro; D S McQueen; D J Webb
Journal:  Br J Clin Pharmacol       Date:  1999-05       Impact factor: 4.335

5.  Migraine attack restores the response of vascular smooth muscle cells to nitric oxide but not to norepinephrine.

Authors:  Raffaele Napoli; Vincenzo Guardasole; Emanuela Zarra; Antonietta De Sena; Francesco Saccà; Antonio Ruvolo; Simona Grassi; Speranza Giugliano; Giovanna De Michele; Antonio Cittadini; Pietro Biagio Carrieri; Luigi Saccà
Journal:  World J Cardiol       Date:  2013-10-26

Review 6.  Migraine with and without aura and risk for cardiovascular disease.

Authors:  Bert B Vargas; David W Dodick; Dean M Wingerchuk; Bart M Demaerschalk
Journal:  Curr Atheroscler Rep       Date:  2008-10       Impact factor: 5.113

7.  Prevalence of Raynaud's phenomenon in healthy Turkish medical students and hospital personnel.

Authors:  Necati Cakir; Omer Nuri Pamuk; Salim Dönmez; Ahmet Barutçu; Hidayet Diril; Esin Odabaş; Volkan Kiliçcigil
Journal:  Rheumatol Int       Date:  2008-08-06       Impact factor: 3.580

8.  Endothelial function in migraine: a cross-sectional study.

Authors:  Floris H Vanmolkot; Jan N de Hoon
Journal:  BMC Neurol       Date:  2010-12-01       Impact factor: 2.474

9.  Ergot induced myocardial ischaemia in a patient without vasospastic disorder.

Authors:  I Paz; Y Carmeli
Journal:  J R Soc Med       Date:  1994-01       Impact factor: 18.000

Review 10.  Prevalence, risk factors and associations of primary Raynaud's phenomenon: systematic review and meta-analysis of observational studies.

Authors:  Rozeena Garner; Rakesh Kumari; Peter Lanyon; Michael Doherty; Weiya Zhang
Journal:  BMJ Open       Date:  2015-03-16       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.